KPRX · Kiora Pharmaceuticals Inc · Financials
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $0 | $16.02M | $0 | — | $0 | $12.06K | $2.69M | $1.65M | $407.52K | $669.26K | $0 | — | |
| $9.86M | $10.78M | $7.84M | $4.03M | $3.45M | $5.35M | $3.57M | $5.39M | $8.06M | $10.33M | $8.42M | $2.72M | $531.12K | |
| $5.9M | $5.75M | $5.54M | $4.66M | $8.28M | $5.32M | $4.66M | $4.41M | $4.44M | $4.64M | $5.59M | $3.96M | $1.93M | |
| — | $0 | $15K | $25K | $25K | $25K | $25K | $25K | $6250 | $0 | — | — | — | |
| $42.36K | $24.8K | $19.21K | $51.8K | $41.61K | $45.3K | $33.4K | $51.67K | $38.48K | $19.29K | $5185 | $1257 | $1724 | |
| $12.83M | $12.83M | $11.51M | $12.59M | $12.31M | $14.24M | $6.88M | $9.8M | $12.5M | $14.97M | $14.02M | $6.68M | $2.46M | |
| -$12.83M | -$12.83M | $4.51M | -$12.59M | -$12.31M | -$14.24M | -$6.87M | — | -$10.84M | — | — | — | — | |
| — | — | 28.15% | — | — | — | -56960.51% | — | -656.25% | — | — | — | — | |
| -$12.79M | -$12.81M | $4.53M | -$12.54M | -$12.27M | -$14.19M | -$6.84M | — | -$10.81M | — | — | — | — | |
| — | $19.96K | $21.45K | $11.13K | $8599 | $6851 | $4186 | $325 | $1040 | $1215 | $275 | $1.93M | $441.72K | |
| — | $894K | $1.25M | $173.99K | $56.89K | $1141 | $23.34K | $108.07K | $120.36K | $564 | $3684 | $947 | $1102 | |
| $548.68K | $713.77K | $1.15M | $163.32K | -$1.39M | $272.48K | $19.15K | $107.74K | $119.32K | -$651 | $3409 | -$1.71M | $910.58K | |
| -$12.28M | -$12.12M | $5.66M | -$12.42M | -$13.7M | -$13.96M | -$6.85M | -$7M | -$10.73M | -$14.56M | -$13.34M | -$8.39M | -$1.55M | |
| -$1.29M | -$1.28M | $2.07M | $90.32K | -$113.01K | -$192.6K | $12.06K | $95.4K | $86.05K | -$1.34M | $0 | — | — | |
| -$10.99M | -$10.84M | $3.59M | -$12.51M | -$13.58M | -$13.77M | -$6.86M | -$7.1M | -$10.81M | -$13.22M | -$13.34M | -$8.39M | -$1.55M | |
| — | — | 22.44% | — | — | — | -56901.65% | -264.21% | -654.24% | -3243.52% | -1993.76% | — | — | |
| — | — | — | — | — | — | — | — | — | -$0.93 | -$1.51 | $5177 | $222.48K | |
| -$14.09M | — | — | — | — | — | — | — | — | — | -$13.34M | -$16.62M | -$1.77M | |
| — | — | — | — | — | — | — | — | — | — | -$13.34M | -$8.27M | -$1.77M | |
| USD/shares | -$2.46 | -$2.60 | $0.93 | -$24.25 | -$166.95 | -$514.08 | -$536.40 | — | — | — | — | — | — |
| USD/shares | -$2.50 | -$2.64 | $0.87 | -$24.25 | -$166.95 | -$514.08 | -$536.40 | — | — | — | — | — | — |
| shares | — | 4.17M | 3.87M | 538.01K | 81.37K | 26.79K | 12.75K | 8836.1639 | 6571.0639 | 39.61K | 24.54K | 17.12K | 535.7583 |
| shares | — | 4.1M | 4.13M | 538.01K | 81.37K | 26.79K | 12.75K | 8836.1639 | 6571.0639 | 39.61K | 24.54K | 17.12K | 535.7583 |
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 216 similar-size Biotechnology companies (of 536 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| Reportable Segment | $0 | $16,020,000 |